Polypharmacy in RA tied to several comorbidities
Polypharmacy occurs generally in patients with rheumatoid arthritis, with a prevalence of 67.9 percent, and has shown a relationship with a number of comorbidities, according to a study. The researchers stress the need for solutions in managing this problem.
